NIPRIDE RTU (EXELA PHARMA SCIENCES, LLC)
Welcome to the PulseAid listing for the NIPRIDE RTU drug offered from EXELA PHARMA SCIENCES, LLC. This Vasodilation [PE],Vasodilator [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | EXELA PHARMA SCIENCES, LLC |
NON-PROPRIETARY NAME: | Sodium Nitroprusside |
SUBSTANCE NAME: | SODIUM NITROPRUSSIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Vasodilation [PE],Vasodilator [EPC] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2017-03-20 |
END MARKETING DATE: | 0000-00-00 |
NIPRIDE RTU HUMAN PRESCRIPTION DRUG Details:
Item Description | NIPRIDE RTU from EXELA PHARMA SCIENCES, LLC |
LABELER NAME: | EXELA PHARMA SCIENCES, LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 0.5(mg/mL) |
START MARKETING DATE: | 2017-03-20 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 51754-1006_0c46c9d4-9923-4cd2-8e83-9228120bb93d |
PRODUCT NDC: | 51754-1006 |
APPLICATION NUMBER: | NDA209387 |
Other SODIUM NITROPRUSSIDE Pharmaceutical Manufacturers / Labelers: